These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 32587958)

  • 1. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in vitro models of the human blood-brain barrier.
    Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; McGary H; Razmpour R; Galie PA; Potula R; Andrews AM; Ramirez SH
    bioRxiv; 2020 Jun; ():. PubMed ID: 32587958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
    Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
    Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 Spike Protein Disrupts Blood-Brain Barrier Integrity via RhoA Activation.
    DeOre BJ; Tran KA; Andrews AM; Ramirez SH; Galie PA
    J Neuroimmune Pharmacol; 2021 Dec; 16(4):722-728. PubMed ID: 34687399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human plasma gelsolin reverses increased permeability of the blood-brain barrier induced by the spike protein of the SARS-CoV-2 virus.
    Suprewicz Ł; Tran KA; Piktel E; Fiedoruk K; Janmey PA; Galie PA; Bucki R
    J Neuroinflammation; 2022 Nov; 19(1):282. PubMed ID: 36434734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 spike S1 subunit protein-mediated increase of beta-secretase 1 (BACE1) impairs human brain vessel cells.
    Choi JY; Park JH; Jo C; Kim KC; Koh YH
    Biochem Biophys Res Commun; 2022 Oct; 626():66-71. PubMed ID: 35970046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penetration of the SARS-CoV-2 Spike Protein across the Blood-Brain Barrier, as Revealed by a Combination of a Human Cell Culture Model System and Optical Biosensing.
    Petrovszki D; Walter FR; Vigh JP; Kocsis A; Valkai S; Deli MA; Dér A
    Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Thiol-Disulfide Balance on the Binding of Covid-19 Spike Protein with Angiotensin-Converting Enzyme 2 Receptor.
    Hati S; Bhattacharyya S
    ACS Omega; 2020 Jul; 5(26):16292-16298. PubMed ID: 32656452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Spike Protein Induces Degradation of Junctional Proteins That Maintain Endothelial Barrier Integrity.
    Raghavan S; Kenchappa DB; Leo MD
    Front Cardiovasc Med; 2021; 8():687783. PubMed ID: 34179146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Poorly Replicates in Cells of the Human Blood-Brain Barrier Without Associated Deleterious Effects.
    Constant O; Barthelemy J; Bolloré K; Tuaillon E; Gosselet F; Chable-Bessia C; Merida P; Muriaux D; Van de Perre P; Salinas S; Simonin Y
    Front Immunol; 2021; 12():697329. PubMed ID: 34386007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of SARS-CoV-2 variants on central nervous system cells and blood-brain barrier functions.
    Proust A; Queval CJ; Harvey R; Adams L; Bennett M; Wilkinson RJ
    J Neuroinflammation; 2023 Aug; 20(1):184. PubMed ID: 37537664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial Cell Activation by SARS-CoV-2 Spike S1 Protein: A Crosstalk between Endothelium and Innate Immune Cells.
    Rotoli BM; Barilli A; Visigalli R; Ferrari F; Dall'Asta V
    Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The S1 subunits of SARS-CoV-2 variants differentially trigger the IL-6 signaling pathway in human brain endothelial cells and downstream impact on microglia activation.
    Stangis M; Adesse D; Sharma B; Castro E; Kumar K; Kumar N; Minevich M; Toborek M
    NeuroImmune Pharm Ther; 2024 Mar; 3(1):7-15. PubMed ID: 38532784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial cells are not productively infected by SARS-CoV-2.
    Schimmel L; Chew KY; Stocks CJ; Yordanov TE; Essebier P; Kulasinghe A; Monkman J; Dos Santos Miggiolaro AFR; Cooper C; de Noronha L; Schroder K; Lagendijk AK; Labzin LI; Short KR; Gordon EJ
    Clin Transl Immunology; 2021; 10(10):e1350. PubMed ID: 34721846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Golgi localization of SARS-CoV-2 spike protein and interaction with furin in cerebral COVID-19 microangiopathy: a clue to the central nervous system involvement?
    Boluda S; Mokhtari K; Mégarbane B; Annane D; Mathon B; Cao A; Adam C; Androuin A; Bielle F; Brochier G; Charlotte F; Chougar L; El Hachimi KH; Eloit M; Haïk S; Hervé D; Kasri A; Leducq V; Lehéricy S; Levavasseur E; Lobsiger C; Lorin de La Grandmaison G; Malet I; Malissin I; Marot S; Marty S; Pérot P; Plu I; Prigent A; Stimmer L; Potier MC; Marcelin AG; Delatour B; Duyckaerts C; Seilhean D
    Free Neuropathol; 2023 Jan; 4():. PubMed ID: 37283933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral microvascular complications associated with SARS-CoV-2 infection: How did it occur and how should it be treated?
    Omidian N; Mohammadi P; Sadeghalvad M; Mohammadi-Motlagh HR
    Biomed Pharmacother; 2022 Oct; 154():113534. PubMed ID: 35994816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of SARS-CoV-2-related Receptors in Cells of the Neurovascular Unit: Implications for HIV-1 Infection.
    Torices S; Cabrera R; Stangis M; Naranjo O; Adesse D; Toborek M
    Res Sq; 2021 Feb; ():. PubMed ID: 33655239
    [No Abstract]   [Full Text] [Related]  

  • 17. Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain.
    Hernández-Parra H; Reyes-Hernández OD; Figueroa-González G; González-Del Carmen M; González-Torres M; Peña-Corona SI; Florán B; Cortés H; Leyva-Gómez G
    Front Cell Neurosci; 2023; 17():1125109. PubMed ID: 36998270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SARS-CoV-2 envelope protein disrupts barrier function in an
    Ju J; Su Y; Zhou Y; Wei H; Xu Q
    Front Cell Neurosci; 2022; 16():897564. PubMed ID: 36082238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantum Dot Biomimetic for SARS-CoV-2 to Interrogate Blood-Brain Barrier Damage Relevant to NeuroCOVID Brain Inflammation.
    Chiang W; Stout A; Yanchik-Slade F; Li H; Terrando N; Nilsson BL; Gelbard HA; Krauss TD
    ACS Appl Nano Mater; 2023 Aug; 6(16):15094-15107. PubMed ID: 37649833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Treatment of Encephalitis Following SARS-Cov-2 Infection: A Case Report.
    Darvishnia D; Ahmadi H; Sanei Motlagh A
    Tanaffos; 2022 Feb; 21(2):257-260. PubMed ID: 36879728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.